Data / Form D filings / Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc.: Form D filings
Quanta Therapeutics, Inc., a biotechnology company in South San Francisco, CA, filed 4 Form D notices with the SEC between 2021 and 2026. The latest, on June 24, 2026, reports $76.2 million sold of a $89.1 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- TWO TOWER PLACE, FLOOR 17, South San Francisco, CA, 94080
- Phone
- (970) 742-4190
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1891891
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Amendment | $89,098,282 | $76,192,272 | $12,906,010 | 17 | May 10, 2023 | sec.gov |
| May 25, 2023 | New notice | $54,999,988 | $50,685,368 | $4,314,620 | 13 | May 10, 2023 | sec.gov |
| Feb 17, 2023 | New notice | $29,999,993 | $29,999,993 | 9 | Feb 9, 2023 | sec.gov | |
| Nov 3, 2021 | New notice | $70,152,314 | $40,152,323 | $29,999,991 | 10 | Oct 20, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Perry Nisen | Executive Officer, Director | |
| Maria Fardis | Director | |
| Rajul Jain | Director | |
| Ying Huang | Director | |
| Derek Metzger | Executive Officer | |
| Maha Katabi | Director | |
| Cameron Pitt | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 22, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Quanta Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.